![Marvin J. Garrett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marvin J. Garrett
General Counsel bei AERIE PHARMACEUTICALS, INC.
Aktive Positionen von Marvin J. Garrett
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AERIE PHARMACEUTICALS, INC. | General Counsel | 24.02.2014 | - |
Karriereverlauf von Marvin J. Garrett
Ehemalige bekannte Positionen von Marvin J. Garrett
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
XOMA CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.05.1994 | 01.06.1999 |
General Counsel | 01.05.1994 | 01.06.1999 | |
CooperVision Pharmaceuticals, Inc. | Präsident | 01.01.1990 | 01.01.1994 |
Southern California Biomedical Council
![]() Southern California Biomedical Council Miscellaneous Commercial ServicesCommercial Services Southern California Biomedical Council, also known as SoCalBio, is an organization that aims to promote the growth and development of the life sciences industry. The non-profit company is based in Los Angeles, CA. The company provides leadership, advocacy, and support to their members, and foster collaboration within the industry. The CEO of the company is Ahmed Enany. | Direktor/Vorstandsmitglied | - | - |
Regulatory Affairs Professionals Society
![]() Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Regulatory Affairs Professionals Society is a non-profit organization that offers healthcare products. The non-profit company is based in Rockville, MD. | Vorsitzender | - | - |
Präsident | - | - | |
ALLERGAN, INC. | General Counsel | - | - |
Iolab Corp. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
General Counsel | - | - | |
ISTA Pharmaceuticals, Inc.
![]() ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | General Counsel | 01.06.1999 | - |
Ausbildung von Marvin J. Garrett
The California State University | Undergraduate Degree |
University of Redlands | Graduate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Operativ
General Counsel | 6 |
Chief Tech/Sci/R&D Officer | 2 |
President | 2 |
Sektoral
Health Technology | 5 |
Commercial Services | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
XOMA CORPORATION | Health Technology |
Private Unternehmen | 7 |
---|---|
Allergan, Inc.
![]() Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
ISTA Pharmaceuticals, Inc.
![]() ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
Aerie Pharmaceuticals, Inc.
![]() Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Regulatory Affairs Professionals Society
![]() Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Regulatory Affairs Professionals Society is a non-profit organization that offers healthcare products. The non-profit company is based in Rockville, MD. | Commercial Services |
Southern California Biomedical Council
![]() Southern California Biomedical Council Miscellaneous Commercial ServicesCommercial Services Southern California Biomedical Council, also known as SoCalBio, is an organization that aims to promote the growth and development of the life sciences industry. The non-profit company is based in Los Angeles, CA. The company provides leadership, advocacy, and support to their members, and foster collaboration within the industry. The CEO of the company is Ahmed Enany. | Commercial Services |
Iolab Corp. | |
CooperVision Pharmaceuticals, Inc. |
- Börse
- Insiders
- Marvin J. Garrett
- Erfahrung